摘要
2019年3月,韩国妇科肿瘤学会(KSGO)发布了9价人乳头瘤病毒(HPV)疫苗临床指南,就该疫苗的有效性、安全性,3剂计划接种的理想年龄,2剂计划接种的有效性等问题进行了探讨,并形成指导性建议。文中对该指南的内容进行归纳、总结并简要解读,为我国医务人员提供切实可行的建议和实践依据。
In March 2019,the Korean society of gynecological oncology(KSGO)has issued the guideline for the nine-valent human papilloma virus(HPV)vaccine.The guideline has discussed the nine-valent HPV vaccine’s effectiveness and safety,the ideal age for the third dose planning,and the effectiveness of the second dose planning,and guiding recommendations were formed.The article summarizes and briefly interprets the content of this guide and provides practical suggestions and practical basis for Chinese medical staff.
作者
吴婧
许芳秀
王春燕
WU Jing;XU Fangxiu;WANG Chunyan(Department of Pharmacy,No.971 Hospital of the Navy of Chinese People's Liberation Army,Qingdao,Shandong,China 266071)
出处
《中国药业》
CAS
2020年第20期5-8,共4页
China Pharmaceuticals
关键词
人乳头瘤病毒
9价疫苗
指南解读
药学服务
human papilloma virus
nine-valent vaccine
guild interpretation
pharmaceutical care
